Abdeljabar El Andaloussi

Dr. Abdeljabar El Andaloussi


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in International Journal of Women's Health
Verified
Journal Article
Open access
PDF file
HEHeba ElHusseini
Heba ElHusseini
HEHoda Elkafas
Hoda Elkafas
MAMohamed Abdelaziz
Mohamed Abdelaziz
SHSunil Halder
Sunil Halder
IAIhor Atabiekov
Ihor Atabiekov
Ayman A. Al-HendyAyman A. Al-Hendy
Ayman A. Al-Hendy
Background: Previously, we reported a significantly higher prevalence of uterine fibroids (UFs) in African American women. This minority group also commonly suffers from vitamin D deficiency. We have demonstrated that 1,25(OH)2D3 attains a fibroid growth inhibitory impact through its ability to block the G1/S (gap 1/synthesis) phase of the cell cycle. Vitamin D is involved in DNA damage as well as in immune response regulation, anti-inflammation, autoimmunity and cancer. Since most of the prior data on vitamin D and UF were generated in vitro via established cell lines, it was necessary to verify and validate this observation in vivo using a diet-induced vitamin D-deficient mouse model. Materials and Methods: Our model of vitamin D lacking function was established using 8-week exposure of C57/BL6 mice to vitamin D-deficient diet provides evidence of different functions accomplished by vitamin D in the regulation of myometrium homeostasis disrupted in the context of uterine fibroid. Results: We found that vitamin D deficiency was associated with increased expression of sex steroid receptors in murine myometrium, increased expression of proliferation related genes, the promotion of fibrosis and enhanced inflammation, and promoted immunosuppression through Tregs expansion in murine myometrium. We also showed that a vitamin D deficient diet enhanced DNA damage in murine myometrium. Conclusion: Our model mimics the effects in humans that a lack of vitamin D has and propels the study of in vivo interaction between inflammation, genomic instability and cell proliferation in the myometrium.

1 November 2018 in Biomedicines
Verified
Journal Article
Open access
PDF file
IAIhor Atabiekov
Ihor Atabiekov
EHElie Hobeika
Elie Hobeika
USUjalla Sheikh
Ujalla Sheikh
AAAbdeljabar El Andaloussi
Abdeljabar El Andaloussi
Ayman A. Al-HendyAyman A. Al-Hendy
Ayman A. Al-Hendy
Premature ovarian insufficiency (POI) is a highly prevalent disorder, characterized by the development of menopause before the age of 40. Most cases are idiopathic; however, in some women the cause of this condition (e.g.; anticancer treatment, genetic disorders, and enzymatic defects) could be identified. Although hormone-replacement therapy, the principal therapeutic approach for POI, helps alleviate the related symptoms, this does not effectively solve the issue of fertility. Assisted reproductive techniques also lack efficacy in these women. Thus, an effective approach to manage patients with POI is highly warranted. Several mechanisms associated with POI have been identified, including the lack of function of the follicle-stimulating hormone (FSH) receptor, alterations in apoptosis control, mutations in Sal-like 4 genes, and thymulin or basonuclin-1 deficiency. The above mentioned may be good targets for gene therapy in order to correct defects leading to POI. The goal of this review is to summarize current experiences on POI studies that employed gene therapy, and to discuss possible future directions in this field.

15 September 2018 in Biomedicines
Verified
Journal Article
Open access
PDF file
AAAbdeljabar El Andaloussi
Abdeljabar El Andaloussi
PIProsper Igboeli
Prosper Igboeli
AAAmero Amer
Amero Amer
Ayman A. Al-HendyAyman A. Al-Hendy
Ayman A. Al-Hendy
Cancer treatment with specific chemotherapeutic agents has been well documented to have an adverse impact on female fertility leading to premature ovarian failure (POF). The objective of this study is to investigate if chemotherapeutic induced POF can be reversed by the infusion of autologous nucleated peripheral blood cells (PBMC). To reach our goal, mice were treated with a single intraperitoneal injections of busulfan and cyclophosphamide to induce POF. This was followed by transfusion of PBMC. The ovarian morphology and functional parameters were monitored by radioimmunoassay, real-time PCR, immunofluorescence and immunohistochemistry analysis. Our study showed that chemotherapy (CTX) protracted estrous cycle period and repressed E2 production. In addition, CTX decreased the expressions of steroidogenesis markers, CYP-17 synthesis, StAR (steroidogenic acute regulatory protein), and Connexin-43 protein expression in the ovarian follicles. We also observed reduced numbers and sizes of the primordial and primary follicles in CTX-treated mice compared to untreated controls (p < 0.05). When both CTX and untreated control groups were stimulated with gonadotrophin, the control group produced ten times more ova than the CTX group. Finally, the treatment of premature ovarian failure induced by CTX with autologous PBMC transfusion resulted in over-expression and a statistically significant increase in several stem cell markers and restoration of fertility. Infusion with PBMC in CTX further decreased the estrous cycle length by 2.5 times (p < 0.01). We found that transfusion of autologous PBMC to mice with chemotherapy induced POF was very effective at restoring fertility. These results are similar to other studies using bone marrow derived mesenchymal stem cells.

8 November 2018 in International Urology and Nephrology
Verified
Journal Article
Open access
Qiwei YangQiwei Yang
Qiwei Yang
Mohamed AliMohamed Ali
Mohamed Ali
AAAbdeljabar El Andaloussi
Abdeljabar El Andaloussi
Ayman A. Al-HendyAyman A. Al-Hendy
Ayman A. Al-Hendy
Early life exposure to a variety of insults during sensitive windows of development can reprogram normal physiological responses andalter disease susceptibility later in life. During this process, inflammation triggered by a variety of adverse exposures plays an importantrole in the initiation and development of many types of diseases including tumorigenesis. This systematic review article summariesthe current knowledge about the role and mechanism of inflammation in development of diseases. In addition, epigenome alterationrelated to inflammation and treatment options using epigenetic modifiers are highlighted and discussed.

6 August 2018 in Preprints.org
Verified
Preprint
Open access
PDF file
AAAbdeljabar El Andaloussi
Abdeljabar El Andaloussi
PIProsper Igboli
Prosper Igboli
AAAmero Amer
Amero Amer
AAAyman Al-Hendy
Ayman Al-Hendy
Cancer treatment with specific chemotherapeutic agents has been well documented to have an adverse impact on female fertility leading to premature ovarian failure (POF). The objective of this study was to investigate if chemotherapeutic induced POF can be reversed with an infusion of autologous nucleated peripheral blood cells (PBMC). To reach our goal, mice were treated with a single intraperitoneal injections of busulfan and cyclophosphamide to induce POF. This was followed by transfusion of PBMC. The ovarian morphology and functional parameters were monitored by radioimmunoassay, real-time PCR, immunofluorescence and immunohistochemistry analysis. Our study showed that chemotherapy (CTX) protracted estrous cycle period and repressed E2 production. CTX decreased the expressions of steroidogenesis markers- CYP-17 synthesis, StAR and Connexin-43 protein expression from the ovarian follicles. We also observed reduced numbers and sizes of the primordial and primary follicles in CTX-treated mice compared to untreated controls (P < 0.05). When both CTX and untreated –control groups were stimulated with gonadotrophin, the control group produced ten times more ova than the CTX group. Finally, the treatment of premature ovarian failure induced by CTX with autologous PBMC transfusion resulted in over-expression and a statistically significant increase in several stem cell markers and restoration of fertility. Infusion with PBMC in CTX further decreased the estrous cycle length by 2.5 times (P < 0.01). We found that transfusion of autologous PBMC to mice with chemotherapy induced POF was very effective at restoring fertility. These results are similar to other studies using bone marrow derived mesenchymal stem cells.

26 November 2018
Verified
Book Chapter
Closed access
IAIhor Atabiekov
Ihor Atabiekov
AAAyman Al-Hendy
Ayman Al-Hendy
AAAbdeljabar El Andaloussi
Abdeljabar El Andaloussi